Linguamatics' I2E natural language processing engine helps Sanofi match HLA alleles with multiple sclerosis and associated drug treatments.
Memorial Sloan Kettering Cancer Center also hopes its partnership with analytics vendor Cota will help it prepare for value-based reimbursement.
The new release offers faster biomedical literature searches and delivers contextually relevant results to life sciences and healthcare professionals.
The diabetes care company will use the software under a multi-year agreement.
Linguamatics plans this year to continue building a customer base among large pharmaceutical firms, while Bioalma is eyeing the academic market to help drive growth in 2009.
Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.